LPCAT3 and small cell lung carcinoma: showed that ACSL4 and LPCAT3 are expressed at higher levels in non-neuroendocrine (non-NE-SCLC) than NE-SCLC, contributing to ferroptosis sensitivity and resistance, respectively in the abovementioned cells.